Growth Metrics

Pulmonx (LUNG) Change in Receivables (2019 - 2025)

Pulmonx (LUNG) has disclosed Change in Receivables for 7 consecutive years, with -$1.4 million as the latest value for Q3 2025.

  • Quarterly Change in Receivables fell 492.76% to -$1.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Sep 2025, up 70.96% year-over-year, with the annual reading at $1.3 million for FY2024, 57.86% down from the prior year.
  • Change in Receivables for Q3 2025 was -$1.4 million at Pulmonx, down from $1.2 million in the prior quarter.
  • The five-year high for Change in Receivables was $1.8 million in Q4 2023, with the low at -$1.4 million in Q3 2025.
  • Average Change in Receivables over 5 years is $503421.1, with a median of $715000.0 recorded in 2023.
  • The sharpest move saw Change in Receivables surged 793.41% in 2023, then crashed 492.76% in 2025.
  • Over 5 years, Change in Receivables stood at -$387000.0 in 2021, then soared by 431.78% to $1.3 million in 2022, then skyrocketed by 37.23% to $1.8 million in 2023, then dropped by 1.19% to $1.7 million in 2024, then tumbled by 180.99% to -$1.4 million in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$1.4 million, $1.2 million, and $721000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.